The present invention pertains to closure devices for closing an opening in a body lumen, systems for delivering closure devices, and methods for making and using the same. More particularly, the present invention pertains to closure devices having a rapidly dissolving anchor.
Heart and vascular disease are major problems in the United States and throughout the world. Conditions such as atherosclerosis result in blood vessels becoming blocked or narrowed. This blockage can result in lack of oxygenation of the heart, which has significant consequences because the heart muscle must be well oxygenated in order to maintain its blood pumping action.
Occluded, stenotic, or narrowed blood vessels may be treated with a number of relatively non-invasive medical procedures including percutaneous transluminal angioplasty (PTA), percutaneous transluminal coronary angioplasty (PTCA), and atherectomy. Angioplasty techniques typically involve the use of a balloon catheter. The balloon catheter is advanced over a guidewire such that the balloon is positioned adjacent a stenotic lesion. The balloon is then inflated and the restriction of the vessel is opened. During an atherectomy procedure, the stenotic lesion may be mechanically cut away from the blood vessel wall using an atherectomy catheter.
The non-invasive medical procedures identified above typically gain access to the vasculature through an opening formed into the femoral artery. For obvious reasons, once the procedure is completed the opening the femoral artery will need to be closed. This may include applying direct pressure at the wound site. Alternatively, a device may be used to assist in the closing of the artery.
A wide variety of medical devices have been developed for medical use, for example, use in non-invasive medical procedures. Some of these devices include devices for closing an opening in a body lumen such as the femoral artery. Of the known medical devices, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
The invention provides design, material, manufacturing method, and use alternatives for closure devices with a rapidly dissolving anchor and systems delivering closure devices. An example closure device for closing an opening in a body lumen may include a plug, a rapidly dissolving anchor, and a suture coupling the plug to the anchor. The rapidly dissolving anchor may be configured to dissolve within the body lumen within about 30 days or less. At least a portion of the plug may be disposed adjacent an exterior surface of the body lumen. At least a portion of the rapidly dissolving anchor may be disposed within the body lumen.
An example system for delivering a closure device to an opening in a body lumen to close the opening may include a sheath, a closure device disposed in the sheath, and a push member disposed in the sheath adjacent the closure device. The closure device may include a plug, a rapidly dissolving anchor, and a suture coupling the plug to the anchor. The rapidly dissolving anchor may be configured to dissolve within the body lumen within about 24 hours or less. The push member may be configured to advance the closure device out from the sheath.
An example method for closing an opening in a body lumen may include providing a closure device delivery system, disposing a portion of the sheath within the body lumen, advancing the closure device out from the sheath with the push member, closing the opening in the body lumen with the closure device, and removing the sheath and the push member from the body lumen. The system may include a sheath, a closure device disposed in the sheath, and a push member disposed in the sheath adjacent the closure device. The closure device may include a plug, a rapidly dissolving anchor, and a suture coupling the plug to the anchor. The rapidly dissolving anchor may be configured to dissolve within the body lumen within about 24 hours or less. The push member may be configured to advance the closure device out from the sheath.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
As used herein, the term “sugar” refers to carbohydrates including monosaccharides, disaccharides, oligosaccharides, and polysaccharides having, for example, four (tetrose), five (pentose), six (hexose), seven (heptose), or more carbon atoms. Some examples of monosaccharides sugars include allose, altrose, glucose, mannose, gulose, idose, galactose, talose, ribose, arabinose, xylose, lyxose, erthrose, threose, and glyceraldehyde. Some examples of disaccharides include cellobiose, maltose, lactose, gentiobiose, and sucrose. Some examples of oligosaccharides and/or polysaccharides include cellulose, starch, amylase, amylase, amylopectin, and glycogen. The sugar may be an aldose sugar (i.e., a sugar having an aldehyde functional group) or a ketose sugar (i.e., a sugar having a ketone functional group). The sugar may be a reducing sugar (i.e., a sugar oxidized by Tollens' reagent, Benedict's reagent, or Fehling's reagent) or a non-reducing sugar (i.e., a sugar not oxidized by Tollens' reagent, Benedict's reagent, or Fehling's reagent). The sugar may be cyclic (e.g., furanose, pyranose, etc.) or non-cyclic. The sugar may be either the D or L enantiomer, may rotate polarized light in either the (+) or the (−) direction, and may be either the α a or β anomer.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Less invasive cardiac diagnostic and/or treatment interventions (e.g., angioplasty) are an attractive and efficacious alternative to more invasive procedures such as cardiac bypass. These less invasive procedures typically involve a peripheral puncture that provides access to the vasculature (e.g., at the femoral vein). Once the proper access is obtained, the procedure can be carried out. Following the intravascular procedure, it may be necessary to take one or more steps to close the puncture. This may include application of direct pressure at the wound site. Alternatively, a closure device may be used to seal the opening in the vasculature.
A number of different closure devices exist for closing openings in a body lumen including openings into the femoral artery. These devices typically include an interior or intravascular component called an anchor or backstop, an exterior component called a plug (typically made from collagen), and a filament or suture connecting the anchor an plug together. The anchor is typically made from a relatively slow dissolving or absorbable polymer that is designed to dissolve over a period of about 60-90 days. A number of devices exist that have this general design and at least some of these devices are medically and commercially successful.
Notwithstanding the medical and commercial success of current closure devices, certain obstacles may still exist in the event of device failure or other complications. For example, if the anchor was to dislodge from the plug prematurely, it may migrate downstream in the vasculature where it could damage the lower leg or cause other undesirable complications.
To facilitate the attachment of anchor 14 to plug 16, anchor 14 may also include a projection 24 having a suture opening 26 for suture 18 to extend therethrough as shown in
Plug 16 may comprise any suitable material such as collagen. Any other suitable materials may be used including, for example, clot-promoting materials without departing from the spirit of the invention.
Unlike conventional anchors, anchor 14 may be designed so that is may be “rapidly dissolving”. This feature is emphasized in
A number of design considerations may be utilized to form anchor 14 with desired rate of dissolution. For example, anchor 14 may be made from materials that dissolve relatively quickly in a body lumen (e.g., and/or when exposed to a biological environment). Suitable materials may include sugars (e.g., a monosaccharides, disaccharides, polysaccharide, etc.), polyanhidrides, polyesters (including, for example, polyglycolic acid, polylactide glycolide, etc.), starches, proteins, and the like, combinations thereof, or any other suitable material. In some embodiments, anchor 14 may include a polysaccharide formed into a glassy state.
The time period for these materials to dissolve within a body lumen or rate of dissolution may be generally known based on the properties of the material. For example, sugars may dissolve within about 1 to 30 minutes in a body lumen, or within about 1 to 10 minutes. Polyanhidrides may dissolve at times on the order of about 1 day or so. Polyesters may dissolve in about 30 days. The dissolutions times may also vary depending on thickness. For example, materials that are used as a coating or relatively thin layer may dissolve in a shorter time period. In addition, other additives may also be added to promote or slow the dissolution. For example, hydrogels or similar materials may be added to promote dissolution.
In addition to choosing materials based on their desired dissolution rate, anchor 14 may also include materials that are sufficiently strong and/or resistant to deformation so that can maintain their form while be sutured to plug 16 with suture 18. This may include the use of higher strength and/or slower dissolving materials adjacent to, for example, suture opening 26 so as to maintain the integrity of the bond between plug 16 and anchor 14 for the desired time period.
In at least some embodiments, anchor 14 may be single layered or otherwise be made from a single monolith of material as shown in
In some embodiments, the layers defined in any of the aforementioned anchors 114/214 may be distributed in a substantially uniform manner so that the layers extend longitudinally alongside each other. This need not be the case, however. For example,
Because anchor 214′ is shown in a cross-sectional view that is taken transversely to the cross-section taken in earlier figures (including
The coatings described above may any of the materials disclosed herein or any other suitable material. For example, the coatings may include a poly(glycolic lactic) acid family of materials or other degradable polyesters. In some embodiments, the coating may include a material that dissolves at a somewhat slower rate than the layer(s) of material is covers. However, by virtue of it being thin, it may ultimately dissolve only somewhat slower, at the same rate, or even faster than the underlying layers.
In the embodiments of anchors that include different numbers and/or configurations of layers and/or coatings may utilize different materials for at least some of the layers and/or coatings. These materials may include materials that dissolve at different rates within a body lumen. Combining these materials may allow these anchors to have the desired rate of dissolution within the body lumen. For example, the anchors disclosed and contemplated may utilize two or more different materials, three or more different materials, four or more different materials, five or more different materials, six or more different materials, etc. Some embodiments of anchors may have a plurality of layers and/or coatings that are made from the same material. These embodiments may also include additional layers and/or coatings that are made from different materials.
With the above general configurations of layers and/or coatings in mind, any of the anchors disclosed above may be configured so as to have the desired dissolution time (and/or rate). For example, embodiments of anchors that include a single layer may include a material that has the desired dissolution time. Alternatively, a singular material having a generally high rate of dissolution may be mixed with materials that are less soluble. This may provide the mixture with the desired rapid dissolution time but at a rate that is longer than the monolithic material alone. For example, an example anchor may include a sugar mixed with protein(s), starch(es), and the like, combinations thereof, or any other suitable material.
System 632 may be advanced through sheath 646 to a position where closure device 610 may be advanced out from sheath 634 and into the femoral artery 22. It can be seen in
With anchor 614 properly arranged, sheath 634 and/or introducer 646 may be withdrawn proximally from the femoral artery 22 so that anchor 614 is positioned in the desired location.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims priority to U.S. Provisional Application No. 61/031,456 filed Feb. 26, 2008.
Number | Date | Country | |
---|---|---|---|
61031456 | Feb 2008 | US |